Opko Health Inc (OPK) |
|
5.26 0.24 (4.78%)
|
01-27 01:52 |
|
Open: |
5.09 |
Pre. Close: |
5.02 |
|
High:
|
5.52 |
Low:
|
4.8518 |
|
Volume:
|
16,902,123 |
Market Cap:
|
3,524M |
|
|
|
|
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
5.528 - 5.551 |
5.551 - 5.574 |
|
Low:
|
4.801 - 4.822 |
4.822 - 4.843 |
|
Close:
|
5.224 - 5.262 |
5.262 - 5.302 |
|
Technical analysis |
as of: 2021-01-26 4:47:20 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time. |
| Target: |
Six months: 6.45  One year: 7.53 |
| Support: |
Support1: 4.51 Support2: 3.88 |
| Resistance: |
Resistance1: 5.52 Resistance2: 6.45 |
| Pivot: |
4.53 |
| Moving Average: |
MA(5): 4.71 MA(20): 4.40
MA(100): 4.03 MA(250): 3.27 |
| MACD: |
MACD(12,26): 0.14 Signal(9): 0.07 |
| Stochastic oscillator: |
%K(14,3): 78.74 %D(3): 68.97 |
| RSI: |
RSI(14): 71.89 |
| 52-week: |
High: 6.47 Low: 1.12 Change(%): 246.1 |
| Average Vol(K): |
3-Month: 832506 10-Days: 758310 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.OPK has closed above the upper band by 21.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 12.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 26 Jan 2021
Noteworthy Tuesday Option Activity: CHEF, OPK, AXSM - Nasdaq
Mon, 25 Jan 2021
Is OPKO Health (NASDAQ:OPK) Using Too Much Debt? - Simply Wall St
Thu, 14 Jan 2021
OPKO Health's (OPK) BioReference Extends Digital Health Access - Yahoo Finance
Wed, 13 Jan 2021
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q’20 Guidance - Yahoo Finance
Wed, 13 Jan 2021
OPKO Health, Inc. (OPK) CEO Phil Frost Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript) - Seeking Alpha
Mon, 04 Jan 2021
OPKO Health's (OPK) BioReference Starts Fan Testing Program - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
670 |
| Shares Float (M) |
382 |
|
% Held by Insiders
|
40.08 |
|
% Held by Institutions
|
30.38 |
|
Shares Short (K)
|
123,660 |
|
Shares Short P. Month (K)
|
130,220 |
Stock Financials |
|
EPS
|
-0.180 |
|
EPS Est This Year
|
-0.190 |
|
EPS Est Next Year
|
-0.080 |
|
Book Value (p.s.)
|
2.420 |
|
Profit Margin
|
-9.79 |
|
Operating Margin
|
-1.96 |
|
Return on Assets (ttm)
|
-0.6 |
|
Return on Equity (ttm)
|
-7.0 |
|
Qtrly Rev. Growth
|
87.1 |
|
Gross Profit (p.s.)
|
0.395 |
|
Sales Per Share
|
1.746 |
|
EBITDA (p.s.)
|
0.097 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-41 |
|
Levered Free Cash Flow (M)
|
-60 |
Stock Valuations |
|
PE Ratio
|
-29.22 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.17 |
|
Price to Sales
|
3.01 |
|
Price to Cash Flow
|
-86.34 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
